ulcerative colitis
Conditions
Interventions
clinical group:Qing Chang Wen Zhong decoction
control:Mesalazine Enteric-coated Tablets or Medichemie Ettingen
Sponsors
Dongfang Hospital Affiliated to Beijing University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. In accordance with the diagnosis criteria of ulcerative colitis in Western medicine and (1) severity mild or moderate; (2) active stage. 2. TCM syndrome differentiation: intermingled heat and cold,and stagnant dampness-heat; 3. Aged between 18 and 65 years old, male and female; 4. Voluntary and signed informed consent; 5. Willing to participant.
Exclusion criteria
Exclusion criteria: (1)Patients with severe complications: local stenosis, intestinal obstruction, intestinal perforation, toxic dilation of the colon, colon cancer, rectal cancer and diseases of anus; (2)Pregnancy or are preparing to pregnant women, breast-feeding women; (3)Patients of allergic constitution and multi-drug allergies; (4)Combined liver, kidney, hematopoietic system, endocrine system and other serious diseases and mental illness,or combined serious mental illness; (5) Patients with other treatment options for ulcerative colitis, besides the treatment options of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of colonic mucosa lesions;disease activity index;Truelove index;IBQD; | — |
Countries
China
Contacts
Public ContactXiaowei Chen
Department of Digestion internal, Dong Fang Hospital Affiliated to Beijing University of Traditional Chinese Medicine
Outcome results
None listed